Celgene Pays Anokion $45M for Autoimmune Research, Option to Buy

From Xconomy VC, Deals, & Startups
January 9, 2017 - 5:58pm
Celgene hasn’t been afraid to strike deals with early stage biotech companies and the Summit, NJ-based drug developer is at it again, this time entering a research partnership with Anokion in autoimmune diseases. Under the deal announced Monday, Celgene (NASDAQ: CELG) is paying Anokion $45 million up front. Anokion, which is based in Lausanne, Switzerland […]


Continue reading this article »